FindTrial
Sign In

COVID-19 Siddha Treatment

Documentation, validation and exploring the efficacy of Envagai Thervu (Eight Diagnostic Methods) COVID 19 cases â?? Observational study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2021/06/034149
Enrollment
20
Registered
2021-06-10
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere

Interventions

Intervention1: Nil: Nil

Sponsors

Dr J Jeyavenkatesh
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All Covid Positve Patients Either RTPCR Positive Or CT Chest Confirmed Or Both.

Exclusion criteria

Exclusion criteria: Pregnancy Lactation Spo2 Below 80 RR Above 40 PR Above 60 But Below 120 Non-Urinary Catheterized Transgender Known Cardiac Patients IDDM Hba1c Above 10

Design outcomes

Primary

MeasureTime frame
Observation of Tongue, Colour, Speech, Eyes, Skin, Stools, Urine and Pulse DiagnosisTimepoint: 3 and 5th day—

Secondary

MeasureTime frame
Clinical prognosis and change of pattern in Neikuri (Urine analysis by Siddha method) analysisTimepoint: DAY 7—

Countries

India

Contacts

Public ContactMr S Senthilnathan

Kokila Siddha Hospital and Research Centre

jeyyavenkateshdrs@gmail.com914522675674

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026